Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03493321
Other study ID # CEBD-CU-2018-03-07
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date August 22, 2019
Est. completion date September 30, 2019

Study information

Verified date August 2019
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

this research will evaluate the effect of PRF with different bioactive materials in dentistry


Description:

PRF will be used with MTA and Theracal to evaluate its effect upon these materials in reliving pain and maintains the teeth vitality in permanent teeth with closed apices, in order to improve the materials outcome.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 98
Est. completion date September 30, 2019
Est. primary completion date August 22, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 16 Years to 35 Years
Eligibility Inclusion Criteria:

- Patients suffering from Symptomatic pulpitis.

- Patients should be free from any systemic disease that may affect normal healing and predictable outcome.

- Patients who will agree to the consent and will commit to follow-up period.

- Patients with mature root.

- Patients with no periapical lesion.

- Patients with localized pain.

- Posterior teeth only will be involved

Exclusion Criteria:

- Patients with immature roots.

- Patients with any systemic disease that may affect normal healing.

- Patients with periapical lesions or infections.

- Pregnant females.

- Patients who could/would not participate in a 1-year follow-up.

- Patients with fistula.

- Patients with necrotic pulp.

- Patients with old age.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
PRF with Theracal
using the PRF which is a new technique with an bioactive material which is the Theracal to evaluate its effect upon the radicular pulp tissue

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Outcome

Type Measure Description Time frame Safety issue
Primary pain after the process Questionnaire by asking the patient about the pain intensity 1 year
Secondary dentin bridge formation X-ray 1 year
Secondary no periapical radiolucency X-ray 1 year
See also
  Status Clinical Trial Phase
Completed NCT00772525 - Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis Phase 2
Terminated NCT03247413 - Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation Phase 4
Withdrawn NCT00037115 - Induction Therapy With a Single High Dose Bolus of Intravenous Methotrexate With Leucovorin Rescue, Prior to Initiation of AVONEX® Treatment, in Patients Presenting With a First Acute Demyelinating Event. Phase 4
Recruiting NCT05095844 - National Vaccine Adverse Event Reporting Survey and Etiology
Recruiting NCT02107417 - Study of TENS in Reducing Symptoms of Peripheral Neuropathy Induced by Chemotherapy N/A
Recruiting NCT04448938 - RESting-state Functional MRI in Patients With Optic Neuritis for ANticipation of reCovEry